Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...

A research team led by professor Nan-Hee Kim from Korea University's College of Medicine (Nan-Hee Kim and So-Young Park of Department of Endocrinology and Metabolism; Min-Hee Kim and Jae-Young Kim of ...

Can deep learning catch chronic illness before symptoms show? This article explores how time-aware neural networks are reshaping early detection and care planning for conditions like diabetes and COPD ...

Africa accounts for the majority of global births affected by the condition, yet universal newborn screening remains rare.

One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the umbilical cords of children who were later diagnosed with the disease. In ...